Long-term migraine medicine study for kids with migraine attacks
Treatments studied
Part of Brain & nervous system, Ear, nose & throat, Eyes & vision clinical trials.
This Phase 3 study checks the long-term safety of rimegepant, a migraine treatment, in children and teens. You might join if your child has had migraine for at least 6 months and still gets a certain number of moderate-to-severe migraine attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has had migraine (with or without aura) for at least 6 months
- During the last 2 months, they had 1 to 8 moderate-to-severe migraine attacks per month
- They have migraine days that need treatment during the study’s observation period
- They are able to tell migraine from other types of headaches
- They meet the age and weight limits (at least 6 years old, under 18; weight over 15 kg—EU teens 12–<18 may need over 25 kg)
- They can have blood drawn (good vein access)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the medicine rimegepant is safe for people with migraine. You may be able to join if you have had migraine for at least a year, have 4–14 migraine days per month, and have not had good results with other migraine medicines called triptans.
This study tests whether taking an additional dose of rimegepant (a migraine medicine you may already use) is safe and helpful for adults with migraine. Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist—a type of medicine that blocks a protein involved in migraine pain.
This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.
This study tests whether the medicine rimegepant can help prevent migraines that happen around your period. It is for women with regular menstrual cycles who have a history of menstrual migraines.
This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.
This trial studies a medicine for stopping a migraine attack in children and teens. It may help families understand which treatment works best during acute (during-attack) migraine pain.
Hear when a new Acute Treatment of Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.